Table 28 Risperidone for children and adolescents with avoidant/restrictive food intake disorder
From: Canadian practice guidelines for the treatment of children and adolescents with eating disorders
| Certainty assessment | Impact | Certainty | Importance | ||||||
|---|---|---|---|---|---|---|---|---|---|
| № of studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | |||
| Weight, psychological symptoms | |||||||||
| 1 | Case Report | very serious a | not serious | not serious | not serious | none | In two cases of ARFID on dose of 1 mg daily of risperidone. Weight gain was observed to target weight over several weeks. | ⨁◯◯◯ VERY LOW | IMPORTANT |
| very serious a | not serious | not serious | not serious | none | Oppositional behaviour and rigidity around eating improved. | ⨁◯◯◯ VERY LOW | IMPORTANT | ||